Clinical Trials Directory

Trials / Unknown

UnknownNCT03380481

SouthErn China REgisTry for Stroke on Traditional Chinese Medicine

Status
Unknown
Phase
Study type
Observational
Enrollment
10,000 (estimated)
Sponsor
Yefeng Cai · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Stroke is the first most common cause of death in China and one of the major causes of functional disability in the adult population.The burden of stoke is significantly increased in China in recent years. In order to investigate the prognosis of stroke, with diagnostic and treatment information of traditional Chinese medicine (TCM), and assess the effectiveness and safety of TCM for stroke in southern China, the investigators will conduct this multicenter prospective registry study in southern China. This study will recruit 10,000 consecutive eligible patients with acute stroke from more than 50 hospitals. 24 months follow-up will be carried out on-site in hospitals and by telephone to track endpoint (including all-cause mortality, composite cerebrovascular and cardiovascular events at one and two year follow up, and neurological and functional assessments).

Conditions

Interventions

TypeNameDescription
OTHERobservational only-no interventionObservational only and no predesigned interventions in this study.

Timeline

Start date
2018-01-15
Primary completion
2020-12-31
Completion
2020-12-31
First posted
2017-12-21
Last updated
2018-03-08

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT03380481. Inclusion in this directory is not an endorsement.